Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 10;5(9):e007425.
doi: 10.1136/bmjopen-2014-007425.

Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study

Jakob Christensen  1 , Henrik Søndergaard Pedersen  2 , Maiken Ina Siegismund Kjaersgaard  3 , Erik Thorlund Parner  3 , Mogens Vestergaard  2 , Merete Juul Sørensen  4 , Jørn Olsen  5 , Bodil Hammer Bech  5 , Lars Henning Pedersen  6
Affiliations

Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study

Jakob Christensen et al. BMJ Open. .

Abstract

Objectives: It is unknown if prenatal exposure to antiepileptic drugs (AEDs) increases the risk of low Apgar score in offspring.

Setting: Population-based study using health registers in Denmark.

Participants: We identified all 677 021 singletons born in Denmark from 1997 to 2008 and linked the Apgar score from the Medical Birth Register with information on the women's prescriptions for AEDs during pregnancy from the Danish Register of Medicinal Product Statistics. We used the Danish National Hospital Registry to identify mothers diagnosed with epilepsy before birth of the child. Results were adjusted for smoking and maternal age.

Results: Among 2906 children exposed to AEDs, 55 (1.9%) were born with an Apgar score ≤7 as compared with 8797 (1.3%) children among 674 115 pregnancies unexposed to AEDs (adjusted relative risk (aRR)=1.41 (95% CI 1.07 to 1.85). When analyses were restricted to the 2215 children born of mothers with epilepsy, the aRR of having a low Apgar score associated with AED exposure was 1.34 (95% CI 0.90 to 2.01) When assessing individual AEDs, we found increased, unadjusted RR for exposure to carbamazepine (RR=1.86 (95% CI 1.01 to 3.42)), valproic acid (RR=1.85 (95% CI 1.04 to 3.30)) and topiramate (RR=2.97 (95% CI 1.26 to 7.01)) when compared to unexposed children.

Conclusions: Prenatal exposure to AEDs was associated with increased risk of being born with a low Apgar score, but the absolute risk of a low Apgar score was <2%. Risk associated with individual AEDs indicate that the increased risk is not a class effect, but that there may be particularly high risks of a low Apgar score associated with certain AEDs.

Keywords: EPIDEMIOLOGY; PERINATOLOGY.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Unadjusted relative risk of low Apgar score (≤7) by antiepileptic drug exposure during pregnancy (monotherapy and polytherapy combined).
See this image and copyright information in PMC

References

    1. APGAR V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260–7. 10.1213/00000539-195301000-00041 - DOI - PubMed
    1. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 2001;344:467–71. 10.1056/NEJM200102153440701 - DOI - PubMed
    1. Papile LA. The Apgar score in the 21st century. N Engl J Med 2001;344:519–20. 10.1056/NEJM200102153440709 - DOI - PubMed
    1. Ehrenstein V, Sorensen HT, Pedersen L et al. . Apgar score and hospitalization for epilepsy in childhood: a registry-based cohort study. BMC Public Health 2006;6:23 10.1186/1471-2458-6-23 - DOI - PMC - PubMed
    1. Harden CL, Meador KJ, Pennell PB et al. . Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:133–41. 10.1212/WNL.0b013e3181a6b312 - DOI - PMC - PubMed

Publication types

Substances